Comparative Effectiveness and Safety of Oral Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction: A Systematic Review and Network Meta-analysis-Reference-Cited by-同舟云学术

Comparative Effectiveness and Safety of Oral Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction: A Systematic Review and Network Meta-analysis

Published:2013-05 Issue:5 Volume:63 Page:902-912
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Yuan JinQiu,Zhang RenJie,Yang ZuYao,Lee Jack,Liu YaLi,Tian JinHui,Qin XiWen,Ren ZhengJia,Ding Hong,Chen Qing,Mao Chen,Tang JinLing

Publisher

Elsevier BV

Subject

Urology

Reference52 articles.

1. Optimal calcium intake. NIH Consensus Development Panel on Optimal Calcium Intake;JAMA,1994

2. Prevalence of erectile dysfunction in male stroke patients, and associated co-morbidities and risk factors;Bener;Int Urol Nephrol,2008

3. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study;Feldman;J Urol,1994

4. Importance of and satisfaction with sex among men and women worldwide: results of the global better sex survey;Mulhall;J Sex Med,2008

5. Erectile dysfunction;Wessells;J Urol,2007

Cited by 207 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Les traitements de la dysfonction érectile : ce que les infirmiers doivent savoir;Progrès en Urologie - FMC;2024-09

2. With great power comes great responsibility: the cardiovascular risk related to PDE5Is assumption;Minerva Urology and Nephrology;2024-05

3. Major adverse cardiovascular events related to phosphodiesterase 5 inhibitors: analysis of real-life data from Eudra-Vigilance database;Minerva Urology and Nephrology;2024-05

4. High prevalence of erectile dysfunction in men with hyperthyroidism: a meta-analysis;BMC Endocrine Disorders;2024-04-30

5. Phosphodiesterase type 5 inhibitors related hearing impairment: a real world study based on the FDA adverse event reporting system;Scientific Reports;2024-04-28